Attitudes toward colorectal cancer screening tests
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
OBJECTIVE: To examine patient and physician preferences in regard to 5 colorectal cancer screening alternatives endorsed by a 1997 expert panel, determine the impact of patient and physician values regarding certain test features on screening preference, and assess physicians’ perceptions of patients’ values.
DESIGN: Cross-sectional survey.
SETTING: A general internal medicine practice at an academic medical center in 1998.
PARTICIPANTS: Patients (N=217; 76% response rate) and physicians (N=39; 87% response rate) at the study setting.
MEASUREMENTS AND MAIN RESULTS: Patients preferred fecal occult blood testing (43%) or colonoscopy (40%). In patients for whom accuracy was the most important test feature, colonoscopy (62%) was the preferred screening method. Patients for whom invasive test features were more important preferred fecal occult blood testing (76%; P<.001). Patients and physicians were similar in their values regarding the various test features. However, there was a significant difference between physicians’ perceptions of which test features were important to patients compared with the patients’ actual responses (P<.001). The largest discrepancy was for accuracy (patient actual 54% vs physician opinion 15%) and discomfort (patient actual 15% vs physician opinion 64%).
CONCLUSIONS: Patients have distinct preferences for colorectal cancer screening tests that are associated with the importance placed on certain test features. Physicians incorrectly perceive those factors that are important to patients. Physicians should incorporate patient values in regard to certain test features when discussing colorectal cancer screening with their patients and when eliciting their screening preferences.
- Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. Ca Cancer J Clin. 2000;50:7–33.
- Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. (published erratum appears in N Engl J Med 1993;329:672) N Engl J Med. 1993;328:1365–71.
- Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434–7. CrossRef
- Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondegaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71. CrossRef
- Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-ocult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7. CrossRef
- Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–7. CrossRef
- Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572–5. CrossRef
- Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoid-oscopy. J Natl Cancer Inst. 1993;85:1311–8. CrossRef
- Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977–81. CrossRef
- Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341:736–40. CrossRef
- Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. Ann Intern Med. 1995;123:904–10.
- Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–7. CrossRef
- U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd Ed. Alexandria, Va: International Medical Publishing; 1996.
- Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers and update 2001: testing for early lung cancer detection. Ca Cancer J Clin. 2001;51:38–75. CrossRef
- Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594–642. CrossRef
- Brody DS. The patient’s role in clinical decision-making. Ann Intern Med. 1980;93:718–22.
- Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med. 1984;100:258–68.
- Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406–22. CrossRef
- Centers for Disease Control and Prevention. Trends in screening for colorectal cancer—United States, 1997 and 1999. Morb Mortal Wkly Rep. 2001;50:162–6.
- Quill TE, Brody H. Physician recommendations and patient autonomy: finding a balance between physician power and patient choice. Ann Intern Med. 1996;125:763–9.
- Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med. 1999;14:432–7. CrossRef
- Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45:211–8.
- Braddock CH, Fihn SD, Levinson W, Jonsen AR, Pearlman RA. How doctors and patients discuss routine clinical decisions: informed decision making in the outpatient setting. J Gen Intern Med. 1997;12:339–45.
- Pignone MP, Bucholtz D, Harris R. Patient interest and preferences for colon cancer screening. J Gen Intern Med. 1998;13(Suppl 1):96.
- Dolan JG. Are patients capable of using the analytic hierarchy process and willing to use it to help make clinical decisions? Med Decis Making. 1995;15:76–80. CrossRef
- Schoen RE, Weissfeld JL, Kuller LH. Sigmoidoscopy use among primary care physicians. Prev Med. 1995;24:249–54. CrossRef
- American Cancer Society. 1989 survey of physicians’ attitudes and practices in early cancer detection. Ca Cancer J Clin. 1990;40:77–101.
- Eraker SA, Polister P. How decisions are reached: physician and patient. Ann Intern Med. 1982;97:262–8.
- Redelmeier DA, Rozin P, Kahneman D. Understanding patients’ decisions: cognitive and emotional perspectives. JAMA. 1993;270:72–6. CrossRef
- http. www.medicare.gov/publications/pubs/pdf/prevent.pdf
- Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000;133:573–84.
- Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954–61. CrossRef
- Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening—a randomized, controlled trial. Ann Intern Med. 2000;133:761–9.
- Freimuth VS, Quinn SC, Thomas SB, Cole G, Zook E, Duncan T. African Americans’ views on research and the Tuskegee Syphilis Study. Soc Sci Med. 2001;52:797–808. CrossRef
- Attitudes toward colorectal cancer screening tests
Journal of General Internal Medicine
Volume 16, Issue 12 , pp 822-830
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- colorectal cancer screening
- patient preferences
- patient attitudes
- physician attitudes
- screening guidelines
- Industry Sectors
- Author Affiliations
- 1. the Sections of General Internal Medicine, Boston Medical Center, Boston University, Boston, Mass.
- 3. Gastroenterology, Boston Medical Center, Boston University, Boston, Mass.